
The series concludes looking at the proposition that patients with rare and devastating disorders require and deserve a higher acuity of care and service that only an accredited rare pharmacy can deliver.

The series concludes looking at the proposition that patients with rare and devastating disorders require and deserve a higher acuity of care and service that only an accredited rare pharmacy can deliver.

Challenges and impact of rare diseases are faced by pharmacy stakeholders.

The rarity of disease states coupled with novel medication mechanisms and high costs lead to complexities in accessing treatment and optimizing outcomes.

Published: July 30th 2020 | Updated:

Published: August 28th 2020 | Updated:

Published: November 18th 2020 | Updated: